Table 1.
No Bacterial Infection (n = 298) | Bacterial Infection (n = 362) | P Value | |
---|---|---|---|
Age | 57 [14] | 56 [15] | .138 |
Number Males | 162 (54.4%) | 193 (53.3%) | .788 |
Receiving Hemodialysis | 109 (35.4%) | 150 (40.5%) | .494 |
Received Antibiotics | 193 (62.7%) | 242 (65.1%) | .518 |
Procalcitonin | 1.1 [4.6] | 3.8 [22.8] | <.001 |
CRP | 42.3 [131.8] | 72.1 [191.8] | <.001 |
Creatinine | 4.7 [5.4] | 4.4 [4.7] | .161 |
Sepsis as admission diagnosis | 48 (16.1%) | 42 (11.6%) | .111 |
Comorbidities | .218 | ||
Gastrointestinal | 81 (26.3%) | 105 (28.4%) | .545 |
ESLD | 27 (8.8%) | 32 (8.6%) | .957 |
Nephrology | 182 (59.1%) | 233 (63%) | .302 |
Pulmonary | 108 (35.1%) | 122 (33%) | .567 |
Neurological | 53 (17.2%) | 72 (19.5%) | .451 |
Cardiac | 182 (59.1%) | 230 (62.2%) | .415 |
Endocrine | 155 (50.3%) | 182 (49.2%) | .768 |
Hematology | 81 (26.3%) | 109 (29.5%) | .361 |
Malignancy | 32 (10.4%) | 43 (11.6%) | .610 |
Autoimmune | 19 (6.2%) | 31 (8.4%) | .270 |
Abbreviations: CRP, C-reactive protein; ESLD, end-stage liver disease; IQR, interquartile range.
* Data are presented as median [IQR] and number (%).